Stephen Biggar

Goldman Sachs Group Inc (NYSE: GS) and other financial stocks have been in focus as some of the sector’s biggest banks report first-quarter results. Here are some key analyst takeaways from Goldman Sachs’ release. Argus Research analyst Stephen Biggar upgraded the rating to Buy, while...

Shares of American Express Company (NYSE: AXP) hit a fresh 52-week low on Friday and the "coronavirus-inspired selling" is overdone and investors should be buyers of the stock, according to Argus. The American Express Analyst Stephen Biggar upgraded American Express from Hold to Buy with...

American Express Company (NYSE: AXP) reported Thursday with a fourth-quarter top-and-bottom-line miss. The credit card issuer guided to a better-than-expected revenue growth outlook for 2019, mostly due to a "reasonably strong" consumer. Here's how the Street reacted to...

Shares of SunTrust Banks, Inc. (NYSE: STI) have underperformed its regional bank peers over the past six months, but the recent stress test report makes it clear the stock is "disconnected from strong fundamentals," according to Argus. The Analyst Argus Research Company's Stephen...

Strong fee income, a better efficiency ratio than peers and credit quality are behind Argus' bullish Fifth Third Bancorp (NASDAQ: FITB) thesis.  The Analyst Argus analyst Stephen Biggar initiated coverage of Fifth Third with a Buy rating and $36 price target.  The Thesis The bank...

Mastercard Inc (NYSE: MA) reported 20-percent fourth quarter revenue growth to $3.3 billion and adjusted earnings per share of $1.14 — ahead of the $1.12 consensus estimate — on Thursday.  The Analyst Argus analyst Stephen Biggar upgraded MasterCard shares from...

Analysts at Argus Research acknowledge that Anheuser Busch Inbev NV (ADR) (NYSE: BUD)'s days of meaningful growth have likely passed but that doesn't mean the stock is not a good addition to an investor's portfolio. The firm's Stephen Biggar and Phil Seligman initiates coverage of AB-InBev's stock...

Ever since the New York Post reported in mid-May that Colgate-Palmolive Company (NYSE: CL) had admitted to being open to the prospect of selling itself, one legendary investor has repeatedly been mentioned in conjectural conversations - Warren Buffett. Colgate CEO Ian Cook reportedly indicated he...

Argus initiated coverage of Equifax Inc. (NYSE: EFX) at Buy with a $166 price target. Analyst Stephen Biggar estimates a 2017 adjusted EPS of $6.15 and to increase 12.2 percent further to $6.90 in 2018. Related Link: Equifax Board of Directors Declares Quarterly Dividend A Decade of Beats Equifax...

In February, Bioverativ Inc (NASDAQ: BIVV) spun off from Biogen Inc (NASDAQ: BIIB) with two marketed products for the treatment of hemophilia. While expressing optimism regarding Bioverativ being able to establish itself as a “profitable, independent biotechnology company” that is...

TESARO Inc (NASDAQ: TSRO) has strong prospects in immuno-oncology, as it prepares for four commercial launches in 2017 and plans to initiate pivotal studies for several products, Argus’s Stephen Biggar said in a report. He initiated coverage of the company with a Buy rating and a price...

Argus’ Stephen Biggar expressed a positive stance on Berkshire Hathaway Inc. (NYSE: BRK.A) (NYSE: BRK.B), given the stock returns “have more than doubled those of the S&P 500 since 1965” at a CAGR pf 20.8 percent. Biggar initiated coverage of the company with a Hold rating....